OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effect of the Neutralizing SARS-CoV-2 Antibody Sotrovimab in Preventing Progression of COVID-19: A Randomized Clinical Trial
Anil Kumar Gupta, Yaneicy Gonzalez‐Rojas, Erick Stanley Petersen Juárez, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 15
Anil Kumar Gupta, Yaneicy Gonzalez‐Rojas, Erick Stanley Petersen Juárez, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 15
Showing 15 citing articles:
An updated practical guideline on use of molnupiravir and comparison with agents having emergency use authorization for treatment of COVID-19
Awadhesh Kumar Singh, Akriti Singh, Ritu Singh, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2022) Vol. 16, Iss. 2, pp. 102396-102396
Open Access | Times Cited: 89
Awadhesh Kumar Singh, Akriti Singh, Ritu Singh, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2022) Vol. 16, Iss. 2, pp. 102396-102396
Open Access | Times Cited: 89
Niclosamide—A promising treatment for COVID‐19
Shivani Singh, Anne Weiss, James A. Goodman, et al.
British Journal of Pharmacology (2022) Vol. 179, Iss. 13, pp. 3250-3267
Open Access | Times Cited: 58
Shivani Singh, Anne Weiss, James A. Goodman, et al.
British Journal of Pharmacology (2022) Vol. 179, Iss. 13, pp. 3250-3267
Open Access | Times Cited: 58
Sotrovimab: First Approval
Young‐A Heo
Drugs (2022) Vol. 82, Iss. 4, pp. 477-484
Open Access | Times Cited: 53
Young‐A Heo
Drugs (2022) Vol. 82, Iss. 4, pp. 477-484
Open Access | Times Cited: 53
SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19
Caroline Hirsch, Yun Soo Park, Vanessa Piechotta, et al.
Cochrane library (2022) Vol. 2022, Iss. 6
Open Access | Times Cited: 38
Caroline Hirsch, Yun Soo Park, Vanessa Piechotta, et al.
Cochrane library (2022) Vol. 2022, Iss. 6
Open Access | Times Cited: 38
Efficacy and safety of sotrovimab in patients with COVID‐19: A rapid review and meta‐analysis
Bahman Amani, Behnam Amani
Reviews in Medical Virology (2022) Vol. 32, Iss. 6
Open Access | Times Cited: 29
Bahman Amani, Behnam Amani
Reviews in Medical Virology (2022) Vol. 32, Iss. 6
Open Access | Times Cited: 29
Differential efficacy and safety of anti-SARS-CoV-2 antibody therapies for the management of COVID-19: a systematic review and network meta-analysis
Jiawen Deng, Kiyan Heybati, Harikrishnaa Ba Ramaraju, et al.
Infection (2022) Vol. 51, Iss. 1, pp. 21-35
Open Access | Times Cited: 26
Jiawen Deng, Kiyan Heybati, Harikrishnaa Ba Ramaraju, et al.
Infection (2022) Vol. 51, Iss. 1, pp. 21-35
Open Access | Times Cited: 26
Comparison of Preprint Postings of Randomized Clinical Trials on COVID-19 and Corresponding Published Journal Articles
Anthony D. Bai, Yunbo Jiang, David Nguyen, et al.
JAMA Network Open (2023) Vol. 6, Iss. 1, pp. e2253301-e2253301
Open Access | Times Cited: 5
Anthony D. Bai, Yunbo Jiang, David Nguyen, et al.
JAMA Network Open (2023) Vol. 6, Iss. 1, pp. e2253301-e2253301
Open Access | Times Cited: 5
Comparative effectiveness of neutralising monoclonal antibodies in high risk COVID-19 patients: a Bayesian network meta-analysis
David J. McConnell, Marie Harte, Cathal Walsh, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 9
David J. McConnell, Marie Harte, Cathal Walsh, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 9
Drug interventions for prevention of COVID-19 progression to severe disease in outpatients: a systematic review with meta-analyses and trial sequential analyses (The LIVING Project)
Johanne Juul Petersen, Caroline Kamp Jørgensen, Pascal Faltermeier, et al.
BMJ Open (2023) Vol. 13, Iss. 6, pp. e064498-e064498
Open Access | Times Cited: 3
Johanne Juul Petersen, Caroline Kamp Jørgensen, Pascal Faltermeier, et al.
BMJ Open (2023) Vol. 13, Iss. 6, pp. e064498-e064498
Open Access | Times Cited: 3
Outpatient therapies for COVID-19: How do we choose?
Todd C. Lee, Andrew M. Morris, Steven A. Grover, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 2
Todd C. Lee, Andrew M. Morris, Steven A. Grover, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 2
Antibody therapies for treatment of non-severe COVID-19
Katie Gourlay, Nicholas Taylor, Eddy Lang
Internal and Emergency Medicine (2022) Vol. 17, Iss. 3, pp. 883-885
Open Access | Times Cited: 1
Katie Gourlay, Nicholas Taylor, Eddy Lang
Internal and Emergency Medicine (2022) Vol. 17, Iss. 3, pp. 883-885
Open Access | Times Cited: 1
Safety and Pharmacokinetics of the Anti-SARS-CoV-2 Monoclonal Antibody, Sotrovimab, Administered by Intravenous Injection in Japanese and Caucasian Healthy Volunteers
Arisa OKAMASA, Malek Okour, Daren Austin, et al.
Kansenshogaku zasshi (2022) Vol. 96, Iss. 2, pp. 39-45
Open Access | Times Cited: 1
Arisa OKAMASA, Malek Okour, Daren Austin, et al.
Kansenshogaku zasshi (2022) Vol. 96, Iss. 2, pp. 39-45
Open Access | Times Cited: 1
Etiotropic therapy of the new coronavirus infection. Expectations and realities. Part 2
Olga Yu. Kuznetsova
Russian Family Doctor (2022) Vol. 26, Iss. 2, pp. 7-12
Closed Access | Times Cited: 1
Olga Yu. Kuznetsova
Russian Family Doctor (2022) Vol. 26, Iss. 2, pp. 7-12
Closed Access | Times Cited: 1
Severe COVID-19 in a kidney transplant recipient with acquired hypogammaglobulinemia: A case report
Mariell Rivedal, Yngvar Lunde Haaskjold, Anne Berit Guttormsen, et al.
Journal of Case Reports and Images in Medicine (2022) Vol. 8, Iss. 2, pp. 1-6
Open Access
Mariell Rivedal, Yngvar Lunde Haaskjold, Anne Berit Guttormsen, et al.
Journal of Case Reports and Images in Medicine (2022) Vol. 8, Iss. 2, pp. 1-6
Open Access
Antibody therapy reverses biological signatures of COVID-19 progression
M. Cyrus Maher, Leah Soriaga, Anil Kumar Gupta, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access
M. Cyrus Maher, Leah Soriaga, Anil Kumar Gupta, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access
